Founded in 1981, Rho Capital Partners is a well-known venture capital firm based in New York. They invest in 2-6 rounds annually, with a focus on deals ranging from $10 to $50 million. The fund has a higher than average number of lead investments and frequently commits exits. Rho Capital Partners typically invests in rounds with 3-4 participants and has funded startups such as Anacor Pharmaceutical and ChargePoint. Their investment areas include security and biotechnology. Rho Capital Partners is the parent company to Rho's three operating divisions, Rho Ventures, Rho Canada Ventures, and Rho Fund Investors. They actively cross-leverage their divisions' networks to generate unique perspectives and insights.